OTCMKTS:CCEL

Cryo-Cell International (CCEL) Stock Forecast, Price & News

$5.28

0.00 (0.00%)

(As of 09/26/2023 ET)

Compare

Today's Range: $5.17
▼
$5.50
50-Day Range: $5.03
▼
$6.31
52-Week Range: $2.69
▼
$7.25

Volume: 14,514 shs
Average Volume: 10,057 shs
Market Capitalization: $43.77 million

P/E Ratio: 18.86
Dividend Yield: N/A
Price Target: N/A

About Cryo-Cell International (OTCMKTS:CCEL) Stock

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.

CCEL Price History

30 days | 90 days | 365 days | Advanced Chart

CCEL Stock News Headlines

August 31, 2023 | benzinga.com

Cryo-electron Microscopy Market worth $2.1 billion by 2028

July 19, 2023 | markets.businessinsider.com

Maxim Group Keeps Their Buy Rating on Cryo-Cell International (CCEL)

September 27, 2023 | Behind the Markets (Ad)

The World's First "$20 Trillion Drug

?" One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see 113,000% gains! Get the name of the stock here >>>

July 14, 2023 | finance.yahoo.com

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results

May 4, 2023 | marketwatch.com

Stem Cell Services Market to Receive Overwhelming Hike in Revenues by 2030 With key Players Paragon Bioservices, APEX Biologix, VcanBio, Cryo-cell

April 28, 2023 | marketwatch.com

Cell Banking Outsourcing Market Research Analysis 2023-2031

April 27, 2023 | marketwatch.com

Global Cord Blood Stem Cells Market by [2023-2029] with Revenue Outsourcing

April 24, 2023 | msn.com

Looking Into Cryo-Cell International's Return On Capital Employed

September 27, 2023 | Chaikin Analytics (Ad)

This Stock Could Go Up 66% or More.

Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023. Click here to get his latest buy. More here.

April 21, 2023 | msn.com

CPS Technologies CEO resigns

April 21, 2023 | msn.com

CRYO-CELL International GAAP EPS of $0.09 beats by $0.13, revenue of $7.82M beats by $0.41M

April 21, 2023 | finance.yahoo.com

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2023 Financial Results

March 30, 2023 | marketwatch.com

2023-2029 Cord Stem Cell Banking Market Size and Industrial Analysis with Market Dynamics | Latest Report by Absolute Reports

March 22, 2023 | marketwatch.com

Cell Banking Outsourcing Market Outlook by 2031

March 1, 2023 | msn.com

CRYO-CELL International GAAP EPS of $0.33 beats by $0.20, revenue of $30.3M beats by $0.46M

March 1, 2023 | finance.yahoo.com

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2022

February 22, 2023 | seekingalpha.com

CCEL Cryo-Cell International, Inc.

February 16, 2023 | marketwatch.com

Stem Cell Services Market 2028 By Product Type, End User, Capacity and Geography

February 16, 2023 | marketwatch.com

Cell Banking Outsourcing Market Size, Share and Forecast 2029 with Top Countries Data

February 15, 2023 | marketwatch.com

Hematopoietic Stem Cell Transplantation (HSCT) Market 2023-2029 With Highly Productive Segment To Expand Outstandingly

February 14, 2023 | marketwatch.com

Cell Banking Outsourcing Market Size 2023 With Presentation Outlook, Horizontal Viewpoint, Global View

February 13, 2023 | marketwatch.com

Cell Banking and Storage Market Size, Analysis with Key Players having Regional Statistics and Application Forecast to 2028

February 10, 2023 | marketwatch.com

Umbilical Cord Blood Banking Market Size Encyclopedic Research Report 2023 which includes Top Key Players, Growth Rate, and Demand Forecast by 2027

November 16, 2022 | benzinga.com

Cryo-Cell International Chairman Trades Company's Stock

October 14, 2022 | finance.yahoo.com

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2022 Financial Results

August 22, 2022 | finance.yahoo.com

Cord Blood Banking Leader Cryo-Cell Announces Special Cash Dividend

August 18, 2022 | seekingalpha.com

Cryo-Cell International to transfer listing from Nasdaq to NYSE

See More Headlines

Receive CCEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryo-Cell International and its competitors with MarketBeat's FREE daily newsletter.

CCEL Company Calendar

Last Earnings: 7/14/2023
Today: 9/26/2023
Next Earnings (Estimated): 10/12/2023
Fiscal Year End: 11/30/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Miscellaneous health & allied services, not elsewhere classified
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:CCEL
CUSIP: N/A
CIK: 862692
Web: www.cryo-cell.com
Phone: (813) 749-2100
Fax: 813-855-4745
Employees: 80
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): $0.28
Trailing P/E Ratio: 18.86
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $2.77 million
Net Margins: 7.38%
Pretax Margin: 9.09%
Return on Equity: -168.11%
Return on Assets: 3.44%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.52
Quick Ratio: 0.48

Sales & Book Value

Annual Sales: $30.34 million
Price / Sales: 1.44
Cash Flow: $0.54 per share
Price / Cash Flow: 9.82
Book Value: ($0.18) per share
Price / Book: -29.33

Miscellaneous

Outstanding Shares: 8,290,000
Free Float: 5,382,000
Market Cap: $43.77 million
Optionable: Not Optionable
Beta: 0.33

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Mr. David I. Portnoy (Age 60)
Chairman & Co-CEO
Comp: $1.07M

Mr. Mark L. Portnoy (Age 59)
Co-CEO & Director
Comp: $764k

Ms. Jill M. Taymans (Age 53)
CFO & VP of Fin.
Comp: $227.99k

Mr. Oleg Mikulinsky (Age 50)
Chief Information Officer
Comp: $360k

Dr. Joanne Kurtzberg M.D.
Medical Director and Member of Medical & Scientific Advisory Board

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

CCEL Stock - Frequently Asked Questions

How have CCEL shares performed in 2023?: Cryo-Cell International's stock was trading at $4.23 at the start of the year. Since then, CCEL stock has increased by 24.8% and is now trading at $5.28.
View the best growth stocks for 2023 here.
When is Cryo-Cell International's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, October 12th 2023.
View our CCEL earnings forecast.
How were Cryo-Cell International's earnings last quarter?: Cryo-Cell International, Inc. (OTCMKTS:CCEL) issued its quarterly earnings results on Friday, July, 14th. The company reported $0.03 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.07) by $0.10. The business had revenue of $7.77 million for the quarter. Cryo-Cell International had a negative trailing twelve-month return on equity of 168.11% and a net margin of 7.38%.
What other stocks do shareholders of Cryo-Cell International own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Cryo-Cell International investors own include NVIDIA (NVDA), Overstock.com (OSTK), Avid Technology (AVID), Boeing (BA), Enphase Energy (ENPH), OPKO Health (OPK), Riot Platforms (RIOT), Aldeyra Therapeutics (ALDX), Alimera Sciences (ALIM) and Allena Pharmaceuticals (ALNA).

What is Cryo-Cell International's stock symbol?: Cryo-Cell International trades on the OTCMKTS under the ticker symbol "CCEL."
How do I buy shares of Cryo-Cell International?: Shares of CCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Cryo-Cell International's stock price today?: One share of CCEL stock can currently be purchased for approximately $5.28.
How much money does Cryo-Cell International make?: Cryo-Cell International (OTCMKTS:CCEL) has a market capitalization of $43.77 million and generates $30.34 million in revenue each year. The company earns $2.77 million in net income (profit) each year or $0.28 on an earnings per share basis.
How can I contact Cryo-Cell International?: Cryo-Cell International's mailing address is 700 Brooker Creek Boulevard Suite 1800, Oldsmar FL, 34677. The official website for the company is www.cryo-cell.com. The company can be reached via phone at (813) 749-2100, via email at investors@cryo-cell.com, or via fax at 813-855-4745.

This page (OTCMKTS:CCEL) was last updated on 9/27/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial